期刊文献+

尿毒症患者颈动脉钙化与钙磷代谢的临床分析 被引量:3

Clinical Analysis of Relationship between Carotid Artery Calcification and Calcium Phosphorus Metabolism Disorder in Patients with Uremia
原文传递
导出
摘要 目的研究终末期肾病(ESRD)患者颈动脉钙化情况与钙磷代谢紊乱的关系。方法对43例ESRD患者应用彩色B型超声仪观测双侧颈动脉内膜-中膜厚度(IMT)及钙化情况,同时抽血检测血钙、磷、血胆固醇、甘油三酯、二氧化碳结合力、血肌酐,并计算钙磷乘积。结果43例ESRD患者24例(55.8%)存在颈动脉钙化。钙化组IMT值、血磷及钙磷乘积较无钙化组显著增高(分别P<0.01、P<0.05、P<0.05),高血磷组二氧化碳结合力水平较血磷不高组明显降低(P<0.05)。结论ESRD患者存在较高的颈动脉钙化率。颈动脉钙化与颈动脉IMT值、血磷、钙磷乘积增高密切相关,血磷与血CO2含量呈负相关,应重视纠正钙磷代谢紊乱和代谢性酸中毒。 Objective To investigate the relationship between carotid artery calcification and calcium phosphorus metabolism disorder in patients with end stage renal disease(ESRD). Methods The intima-media thickness(IMT) and calcification degree of bilateral carotid artery were detected by uhrasonography in 43 patients with ESRD and serum calcium/phosphorus, serum lipid profile,creatinine,CO2CP were checked at the same time. Results Carotid calcification was confirmed in 24 of 43 cases with ESRD(55.8% ). IMT,serum phosphorus and calcium phosphorus product were significantly higher( P 〈 0.01, P 〈 0.05, P 〈 0.05 respectively) in patients with carotid calcification than those in patients without carotid calcification. Higher concentration of serum phosphorus was associated with lower CO2CP(P 〈 0.05 ). Conclusion Carotid calcification was very prevalent in ESRD patients. IMT, serum phosphorus and calcium phosphorus product were closely correlated with carotid calcification in such patients and negative relationship was found between serum phosphorus concentration and CO2CP. To correct the calcium phosphorus disorder and metabolic acidosis is important.
出处 《中华全科医学》 2009年第11期1174-1175,共2页 Chinese Journal of General Practice
基金 广东省深圳市科技计划项目课题(200903047)
关键词 终末期肾病 动脉钙化 钙磷代谢 颈动脉超声 End-stage renal disease Artery calcification Calcium-phosphorus metabolism Carotid ultrasonography
  • 相关文献

参考文献12

  • 1Mazhar AR,Johnson RJ,Gillen D,et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease[ J ]. Kidney Int, 2001,60:324-332.
  • 2陆江辉,陈寒.颈动脉粥样硬化斑块患者高敏C-反应蛋白水平的临床观察[J].实用全科医学,2008,6(4):358-359. 被引量:3
  • 3冯晓菊,马小红.脑梗塞患者颈动脉粥样硬化的超声检测[J].现代诊断与治疗,2004,15(5):284-285. 被引量:6
  • 4Levin NW, Hulbert-Shearon TE, Strawdesman RL, et al. Which causes of death are related to hyperphosphatema in hemodialysis patients? [ J]. J Am Soc nephrol, 1998,9:217.
  • 5Raggi P, Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients[ J]. Am J Kidney Dis,2001,37( 1 Suppl 2) : s62-s65.
  • 6Chen NX, Moe SM. Vascular calcification in chronic kidney disease [ J]. Sen Nephrol,2004,24:61-68.
  • 7Jono S, Mckee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cells [ J ]. Am J Kidney Dis,2001,37 : 1267-1276.
  • 8London GM, Guerin AP, Marchai s SJ, et al. Arterial mediacalcification in end-stage renal disease:impact on all-cause and cardiovascular mortality [ J ]. Nephrol Dial Transplant,2003,18 : 1731-1740.
  • 9Jono S, McKee MD, Murry CE, et al. Phosphate regulationof vascular smooth muscle cell calcification[ J]. Circ Res,2000,87 :E10-E17.
  • 10张怡玲,田丽,张军莉.透析患者血磷状态的观察[J].中华肾脏病杂志,2006,22(1):58-58. 被引量:6

二级参考文献9

共引文献23

同被引文献35

  • 1向茜,郭燕,李万碧,张弦,张永新,杨才,蔡艳,刘乒乒.糖尿病肾病患者血管钙化特点分析[J].慢性病学杂志,2013,13(2):104-108. 被引量:2
  • 2刘杰,苗懿德,高伯山,苟淑芹.老年男性2型糖尿病患者各种钙调激素与骨密度改变的关系[J].中国骨质疏松杂志,2004,10(4):456-458. 被引量:4
  • 3刘毅,许菲菲,郑尘飞,徐玉兰.血液透析维持时间与钙磷代谢紊乱关系分析[J].浙江预防医学,2005,17(7):62-63. 被引量:4
  • 4Azuma K. Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus [ J ]. Clin Calcium, 2009,19 ( 9 ) : 1345-i 352.
  • 5Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vi- tamin D, PTH, calcium, and phosphorus in patients with chronic kid- ney disease: results of the study to evaluate early kidney disease[J]. Kidney Int ,2007,71 ( 1 ) :31-38.
  • 6Krishnan M,Thodis E,Ikonomopoulos D,et al.Predictors of outcomes following bacterial peritonitis in peritoneal dialysis.Perit Dial Int,2002,22:573-581.
  • 7Kendrick J,Teitelbaum I.Strategies for improving long-term survival in peritoneal dialysis patients.Clin J Am Soc Nephrol,2010,5:1123-1131.
  • 8Bethesda US.Department of Health and Human Service,Public Health,National Institutes of Health.United States Renal Data System Report,1998,4:79-83.
  • 9Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32 (5 Suppl 3):S112-119.
  • 10Goodman WG.Recent developments in the management of secondary hyperparathyroidism.Kidney Int,2001,59:1187-1201.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部